Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital

Read full text Summarise with VIRAT
Authors: Jennifer K. Ross, Kimberly Boeser, Matt Hordyk, Bhupinder Manhani, Elizabeth B. Hirsch, Michael D. Evans, William D. Sieling, Susan E Kline, Alison L. Galdys
Cited by: 0
References: 7

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care. In this report we demonstrate the cost avoidance that this intervention would be expected to generate for patients enrolled in value-based-care plans.

Fields of Study & Subjects

Antibiotic Use and Resistance Pharmaceutical Practices and Patient Outcomes Healthcare cost quality practices

Publication details

Journal / source
Antimicrobial Stewardship & Healthcare Epidemiology
Volume
6
Issue
1
Pages
e86–e86
Publication date
1 April 2026
Language
EN